Theodore E. Maione
Technik-/Wissenschafts-/F&E-Leiter bei Cytogel Pharma LLC
Profil
Theodore E.
Maione is currently the Chief Scientific Officer at Cytogel Pharma LLC.
Previously, he held positions as the Senior Director-Preclinical Division at Transcend Therapeutics, Inc., the President & Chief Scientific Officer at Repligen Corp., and the Chief Scientific Officer & Vice President at SerOptix, Inc. He obtained his undergraduate degree from Michigan State University in 1978 and his doctorate degree from Cornell University in 1983.
Aktive Positionen von Theodore E. Maione
| Unternehmen | Position | Beginn |
|---|---|---|
Cytogel Pharma LLC
 Cytogel Pharma LLC BiotechnologyHealth Technology Cytogel Pharma LLC develops bio-pharmaceutical products. It offers novel analgesic products, useful polymer and hydrogel drug delivery platform technologies. The company was founded in 2002 and is headquartered in Darien, CT. | Technik-/Wissenschafts-/F&E-Leiter | 14.04.2010 |
Ehemalige bekannte Positionen von Theodore E. Maione
| Unternehmen | Position | Ende |
|---|---|---|
SerOptix, Inc.
 SerOptix, Inc. BiotechnologyHealth Technology SerOptix, Inc. operates as a research and American development company. | Technik-/Wissenschafts-/F&E-Leiter | - |
Transcend Therapeutics, Inc.
 Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transcend Therapeutics, Inc. develops and markets pharmaceutical products. It offers its products for oxidative stress, cytokine dysfunction, and multiple organ dysfunctions. The company was founded by Dennis I. Goldberg and Gary W. Pace in 1992 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| REPLIGEN CORPORATION | Präsident | - |
Ausbildung von Theodore E. Maione
| Michigan State University | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Transcend Therapeutics, Inc.
Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transcend Therapeutics, Inc. develops and markets pharmaceutical products. It offers its products for oxidative stress, cytokine dysfunction, and multiple organ dysfunctions. The company was founded by Dennis I. Goldberg and Gary W. Pace in 1992 and is headquartered in Cambridge, MA. | Health Technology |
Cytogel Pharma LLC
Cytogel Pharma LLC BiotechnologyHealth Technology Cytogel Pharma LLC develops bio-pharmaceutical products. It offers novel analgesic products, useful polymer and hydrogel drug delivery platform technologies. The company was founded in 2002 and is headquartered in Darien, CT. | Health Technology |
SerOptix, Inc.
SerOptix, Inc. BiotechnologyHealth Technology SerOptix, Inc. operates as a research and American development company. | Health Technology |
